Market revenue in 2023 | USD 596.9 million |
Market revenue in 2030 | USD 905.7 million |
Growth rate | 6.1% (CAGR from 2023 to 2030) |
Largest segment | Small molecule api |
Fastest growing segment | Small Molecule API |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Small Molecule API, Small Molecule Drug Product |
Key market players worldwide | Wuxi AppTec Co Ltd, EQT Corp, Thermo Fisher Scientific Inc, Lonza Group Ltd, Catalent Inc, Siegfried Holding AG, Boehringer Ingelheim, Labcorp Holdings Inc, Piramal Pharma Solutions, CordenPharma, Cambrex |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to small molecule innovator cdmo market will help companies and investors design strategic landscapes.
Small molecule api was the largest segment with a revenue share of 61.65% in 2023. Horizon Databook has segmented the Denmark small molecule innovator cdmo market based on small molecule api, small molecule drug product covering the revenue growth of each sub-segment from 2018 to 2030.
Denmark has one of the world's most innovative biotech and pharmaceutical markets. It contributes to the advancements in medication development and provides attractive business solutions to global corporations.
To accelerate the approval or development of products in Europe, companies engage in R&D collaborations as well as multiple strategic alliances with universities and research organizations. Denmark conducts the greatest number of clinical trials per capita (around 200 clinical trials/1 million people globally.
It has a high concentration of researchers and is among the nations with the highest R&D expenditure. Denmark has the fourth-best entrepreneurial ecosystem globally. Moreover, outsourcing has increased recently in Denmark's pharmaceutical sector.
Horizon Databook provides a detailed overview of country-level data and insights on the Denmark small molecule innovator cdmo market , including forecasts for subscribers. This country databook contains high-level insights into Denmark small molecule innovator cdmo market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account